$MSRM Mushrooms, Inc. (OTC: MSRM) Announces Divers
Post# of 24979
(Total Views: 114)
Posted On: 08/23/2023 10:13:56 AM
$MSRM Mushrooms, Inc. (OTC: MSRM) Announces Diverse Business Development Team Assembled to Drive Company Growth
https://www.globenewswire.com/news-release/20...rowth.html
ESTERO, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc. (OTC:MSRM) - Mushrooms Inc., proudly introduces its newly-formed Business Development Team, strategically assembled to harness the momentum generated by the company's new technology and Innovation lab development. Comprising accomplished professionals with diverse backgrounds, this team is poised to catapult Mushrooms Inc. into a new era of innovation and growth.
Dr. Reid Jilek's inclusion reflects Mushrooms Inc.'s commitment to synergizing academic prowess with industry innovation. Holding advanced degrees in medical, life sciences, and engineering, Dr. Jilek has published extensively in national and international scientific journals. He was both a Presidential Fellow and a White House Fellow Candidate. Dr. Jilek has developed in excess of 10,000 professional contacts worldwide in the healthcare industry and investment world. His leadership roles in private and public companies, combined with a network spanning the healthcare industry, establish him as a bridge between academia and business growth.
Alicia M. Fantozzi brings over two decades of international corporate and structured finance experience to the team. With a focused track record of driving growth and fostering strategic alliances, her appointment resonates with Mushrooms Inc.'s vision. Having held key roles in strategic initiatives, Alicia's extensive experience uniquely equips her to lead the team's efforts in expanding market presence and revenue streams.
Her role as Principal at ReGen establishes a seed-stage idea lab for biomimicry-based regenerative technologies for water and agriculture., with a concentrated focus on arranging financing, field trials and propagation of advanced innovation initiatives and evaluating complimentary environmental technologies for international sustainability initiatives, Food, Water & Natural Resource Security. Her background, strategic acumen, and commitment to sustainable business practices resonate with Mushrooms Inc.'s mission of revolutionizing the mushroom industry.
Dr. Hyder Khoja, is a leading figure in the life sciences field with over 22 years of expertise spanning drug discovery, developmental science, and policy innovation. Holding a Ph.D. in "Molecular Biology" from INP-ENSAT and post-doctoral training at Michigan State University, his education grounds his visionary approach. Dr. Khoja is a distinguished scientist and visionary in the psychedelic sector, who brings a profound focus to the team. Notably, he is personally committed to pioneering the resurrection of coma patients using psilocybin, adding a transformative dimension to Mushrooms Inc.'s initiatives in the psychedelic space. Dr. Khoja is senior lead scientist in the Company's patent pending Mycelium thread project showcasing the vast background that he brings in support of diverse projects.
David Flores, CEO of PSYC Corporation which owns and operates Psychedelic Spotlight, an industry-leading media authority for the psychedelic sector, brings his visionary leadership to the team. His strategic thinking and experience in the psychedelic landscape perfectly aligns with Mushrooms Inc.'s aspirations for developing multiple facets of the Mushroom sector. His marketing expertise and industry knowledge is integral to the Company as it evolves.
"This enhanced Business Development Team represents a pivotal milestone for Mushrooms Inc.," said Donald Steinberg, Board Director of Mushrooms Inc. "As we make strides in the mushroom sector, our team's collective experience and expertise provide a robust foundation for innovation and growth."
"We are delighted to introduce our exceptional Business Development Team," said Kimberly Zawi Carlson, CEO of Mushrooms Inc. "I've had the privilege of collaborating with these amazing individuals over the past months and I feel that they will collectively bring to Mushrooms Inc what is needed to step forward. I'm honored to announce a formal collaboration with these remarkable and versatile professionals. This strategic step is a direct response to the increasing interest surrounding our patent-pending technology and the forthcoming revenue-generating innovation lab. Alicia Fantozzi, Dr. Reid Jilek, David Flores, and Dr. Hyder Khoja each possess a distinctive skill set that will play a pivotal role in steering our company's growth trajectory. Their combined expertise will propel us forward and better address the investor interest and potential collaborations as we navigate the exciting opportunities ahead."
https://www.globenewswire.com/news-release/20...rowth.html
ESTERO, Fla., Aug. 23, 2023 (GLOBE NEWSWIRE) -- via IBN -- Mushrooms Inc. (OTC:MSRM) - Mushrooms Inc., proudly introduces its newly-formed Business Development Team, strategically assembled to harness the momentum generated by the company's new technology and Innovation lab development. Comprising accomplished professionals with diverse backgrounds, this team is poised to catapult Mushrooms Inc. into a new era of innovation and growth.
Dr. Reid Jilek's inclusion reflects Mushrooms Inc.'s commitment to synergizing academic prowess with industry innovation. Holding advanced degrees in medical, life sciences, and engineering, Dr. Jilek has published extensively in national and international scientific journals. He was both a Presidential Fellow and a White House Fellow Candidate. Dr. Jilek has developed in excess of 10,000 professional contacts worldwide in the healthcare industry and investment world. His leadership roles in private and public companies, combined with a network spanning the healthcare industry, establish him as a bridge between academia and business growth.
Alicia M. Fantozzi brings over two decades of international corporate and structured finance experience to the team. With a focused track record of driving growth and fostering strategic alliances, her appointment resonates with Mushrooms Inc.'s vision. Having held key roles in strategic initiatives, Alicia's extensive experience uniquely equips her to lead the team's efforts in expanding market presence and revenue streams.
Her role as Principal at ReGen establishes a seed-stage idea lab for biomimicry-based regenerative technologies for water and agriculture., with a concentrated focus on arranging financing, field trials and propagation of advanced innovation initiatives and evaluating complimentary environmental technologies for international sustainability initiatives, Food, Water & Natural Resource Security. Her background, strategic acumen, and commitment to sustainable business practices resonate with Mushrooms Inc.'s mission of revolutionizing the mushroom industry.
Dr. Hyder Khoja, is a leading figure in the life sciences field with over 22 years of expertise spanning drug discovery, developmental science, and policy innovation. Holding a Ph.D. in "Molecular Biology" from INP-ENSAT and post-doctoral training at Michigan State University, his education grounds his visionary approach. Dr. Khoja is a distinguished scientist and visionary in the psychedelic sector, who brings a profound focus to the team. Notably, he is personally committed to pioneering the resurrection of coma patients using psilocybin, adding a transformative dimension to Mushrooms Inc.'s initiatives in the psychedelic space. Dr. Khoja is senior lead scientist in the Company's patent pending Mycelium thread project showcasing the vast background that he brings in support of diverse projects.
David Flores, CEO of PSYC Corporation which owns and operates Psychedelic Spotlight, an industry-leading media authority for the psychedelic sector, brings his visionary leadership to the team. His strategic thinking and experience in the psychedelic landscape perfectly aligns with Mushrooms Inc.'s aspirations for developing multiple facets of the Mushroom sector. His marketing expertise and industry knowledge is integral to the Company as it evolves.
"This enhanced Business Development Team represents a pivotal milestone for Mushrooms Inc.," said Donald Steinberg, Board Director of Mushrooms Inc. "As we make strides in the mushroom sector, our team's collective experience and expertise provide a robust foundation for innovation and growth."
"We are delighted to introduce our exceptional Business Development Team," said Kimberly Zawi Carlson, CEO of Mushrooms Inc. "I've had the privilege of collaborating with these amazing individuals over the past months and I feel that they will collectively bring to Mushrooms Inc what is needed to step forward. I'm honored to announce a formal collaboration with these remarkable and versatile professionals. This strategic step is a direct response to the increasing interest surrounding our patent-pending technology and the forthcoming revenue-generating innovation lab. Alicia Fantozzi, Dr. Reid Jilek, David Flores, and Dr. Hyder Khoja each possess a distinctive skill set that will play a pivotal role in steering our company's growth trajectory. Their combined expertise will propel us forward and better address the investor interest and potential collaborations as we navigate the exciting opportunities ahead."
(0)
(0)Scroll down for more posts ▼